Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human IRF4 Anticorps:
anti-Mouse (Murine) IRF4 Anticorps:
anti-Rat (Rattus) IRF4 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Mouse (Murine) Polyclonal IRF4 Primary Antibody pour ICC, IHC - ABIN1859474
Bakalar, Joffe, Schmid, Son, Podolski, Fletcher: Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets. dans Cell 2018
Dog (Canine) Polyclonal IRF4 Primary Antibody pour WB - ABIN2780429
Han, Kraft, Nan, Guo, Chen, Qureshi, Hankinson, Hu, Duffy, Zhao, Martin, Montgomery, Hayward, Thomas, Hoover, Chanock, Hunter: A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. dans PLoS genetics 2008
Human Polyclonal IRF4 Primary Antibody pour ELISA, ICC - ABIN4327575
Nagel, Pommerenke, Meyer, Kaufmann, MacLeod, Drexler: NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia. dans Oncotarget 1970
The differential expression of IRF4 and IRGs observed in Systemic Lupus Erythematosus and Rheumatoid Arthritis can delineate gene expression signatures associated with clinical features and treatment outcomes.
This paper suggests that IRF4 and IRF8 are important in the counter-balancing mechanisms controlling differentiation of plasma cells in myasthenia gravis.
IRF4 inherited genotype may influence melanoma BRAF/NRAS subtype development.
IRF4 was critical for survival in all 8 primary effusion lymphoma cell lines challenged with immunomodulators lenalidomide and pomalidomide. IMiDs triggered downregulation of IRF4 expression independently of both IKZF1 and IKZF3.
We also found that only six of the other 153 known non-synonymous IRF4 variants were loss-of-function. Finally, we found that IRF4 had evolved under purifying selection. autosomal dominant IRF4 deficiency can underlie WD by haploinsufficiency, with age-dependent incomplete penetrance
increased IRF4 protein expression correlates with improved outcome in esophageal squamous cell carcinoma.
this study shows increased IRF4 expression in isolated B cells from common variable immunodeficiency patients
IRF4 is highly expressed in B cells and plasma cells where it plays essential roles in controlling B cell to plasma cell differentiation and immunoglobulin class switching. Overexpression of IRF4 is found in MM patients' derived cells, often as a result of activating mutations or translocations, where it is required for their survival.
Non-methylation of AOX1 and IRF4 were a risk factors for breast cancer.
IRF4 polymorphism is associated with rheumatoid arthritis.
may represent a therapeutic target in adult T-cell leukemia(ATL) because ATL cells select for a mutant of IRF4 with higher nuclear expression and transcriptional activity, and overexpression of IRF4 induces the expansion of T lymphocytes in vivo
The results indicate that an inherited functional variant in IRF4 may independently predict Breslow thickness - the most important prognostic indicator for melanoma.
High IRF4 expression is associated with melanoma.
IRF4 pathway is required for functional development of type 1 regulatory T cells.
In Pakistani population, the frequency of GCB type DLBCL [diffuse large B cell lymphoma ]expressing CD10 and BCL6 is 37.5%, and non- GCB type DLBCL [diffuse large B cell lymphoma ] expressing MUM1 is 62.5%.
Study confirmed a significant role for IRF4 rs12203592 and SLC45A2 rs16891982 in the risk of cutaneous squamous cell carcinoma development in organ transplant recipients.
IRF4 is overexpressed in human non-small cell lung cancer and activates the Notch signaling pathway.
IRF4 signaling is essential for activin A induced regulatory T cells that restrain asthmatic responses.
The data indicate that USP4 interacts with and deubiquitinates IRF4, and also stabilizes IRF4 protein and promotes IRF4 function to facilitate IL-4 expression in Th2 cells, which may be related to the pathological process of rheumatic heart disease.
IRF4 is an independent prognostic factor for general MM patients.
this study shows that PU.1 and IRF4 are transactivators of the Aldh1a2 gene in vitro and ex vivo
These results suggest that IRF4 regulates the clonal expansion of CD8(+) T cells at least in part via the AKT signaling pathway. Moreover, IRF4 regulates the homeostatic proliferation of naive CD8(+) T cells, whereas the maintenance of memory CD8(+) T cells is IRF4-independent.
Data show that interferon regulatory factor 1 (IRF1) occupancy correlates with decreased interferon regulatory factor 4 (IRF4) abundance, suggesting an IRF1-IRF4-binding competition at the interleukin 9 (Il9) locus.
Furthermore, chromatin immunoprecipitation (ChIP) followed by luciferase assays revealed direct binding of Foxo1 to both the Il9 and Irf4 promoters and induces their transactivation.
MBD2 Regulates Th17 Cell Differentiation and Experimental Severe Asthma by Affecting IRF4 Expression
study identifies IRF4 as central regulator of TH1 responses and cellular metabolism. We propose that this function of IRF4 is fundamental for the initiation and maintenance of all TH cell responses.
Nur77 suppresses CD4(+) T cell proliferation and uncover a suppressive role for Irf4 in TH2 polarization; halving Irf4 gene-dosage leads to increases in GATA3(+) and IL-4(+) cells.
Muramyl dipeptide reduces fat inflammation and liver insulin resistance via NOD2. NOD1-activating muropeptides exacerbate glucose intolerance. IRF4 dictates insulin-sensitizing effects of NOD2, but not NOD1, muropeptides.
Young mice had higher levels of IRF4 in the ischemic brains, suggesting that aging has a significant influence on stroke outcomes in mice, which is probably mediated by age-specific inflammatory responses.
IRF4 is highly induced in graft-infiltrating T cells and is required for heart transplant rejection.
The findings indicate that IRF4 functions as a central node in a TCR-responsive transcriptional circuit that establishes and sustains T cell exhaustion during chronic viral infection.
RHS6 is a critical regulatory element for allergic airway inflammation and for coordinate regulation of Th2 cytokine genes by recruiting GATA3, SATB1, and IRF4.
this study shows that epicutaneous sensitization to house dust mite allergen requires interferon regulatory factor 4-dependent dermal dendritic cells
Cell fate and metabolic state are linked by transcriptional regulators, such as IRF4 and FoxO1, with dual roles in lineage and metabolic choice. Instructing some cells to utilize nutrients for anabolism and differentiation while other cells catabolically self-digest and self-renew may enable growth and repair in metazoa.
Here the authors show that concomitant loss of Tet2 and Tet3 in mice at early B cell stage blocked the pro- to pre-B cell transition in the bone marrow, decreased Irf4 expression and impaired the germline transcription and rearrangement of the Igkappa locus.
IRF4 protects arteries against neointima formation by promoting the expression of KLF4 by directly binding to its promoter.
Data show that Fos-Related Antigen-2 (Fra-2) is a key upstream regulator of forkhead box O1 (Foxo1) and interferon regulatory factor 4 (Irf4) expression and influences proliferation and differentiation of B cells at multiple stages.
GM-CSF can mediate inflammation and pain by regulating IRF4-induced CCL17 production
MTORC2 operated in parallel with the IL-4Ralpha-Stat6 pathway.
IRF4a and IRF4b displayed a distinct tissue expression pattern, embryonic stages expression and inducible expression in vivo and in vitro, suggesting that IRF4 paralogues might play different roles in immune system.
The protein encoded by this gene belongs to the IRF (interferon regulatory factor) family of transcription factors, characterized by an unique tryptophan pentad repeat DNA-binding domain. The IRFs are important in the regulation of interferons in response to infection by virus, and in the regulation of interferon-inducible genes. This family member is lymphocyte specific and negatively regulates Toll-like-receptor (TLR) signaling that is central to the activation of innate and adaptive immune systems. A chromosomal translocation involving this gene and the IgH locus, t(6\;14)(p25\;q32), may be a cause of multiple myeloma. Alternatively spliced transcript variants have been found for this gene.
lymphocyte-specific interferon regulatory factor
, multiple myeloma oncogene 1
, PU.1 interaction partner
, Sfpi1/PU.1 interaction partner
, transcriptional activator PIP
, interferon regulatory factor 4
, Interferon regulatory factor 4
, PWWP domain-containing protein MUM1
, melanoma associated antigen (mutated) 1